4911.TWO · G&E
Taiwan · RS rating 12 · As of 2026-10-08
| Price | 28.00 TWD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 17 / 50 / 7 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 12 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -52.2% |
| Sales growth Q/Q | +6.9% |
| Distance from 52-week high | +41.7% |
| Market cap (USD) | $61.2M |